Vaccines

September 16th 2025

Catherine M Stein, Evelyn Griffin, Hilary Blackburn, Kirk Milhoan, and Raymond Pollak join ACIP as the panel prepares to vote on MMRV, Hepatitis B, and COVID-19 recommendations following the June reconstitution.

September 15th 2025

The Los Angeles County Department of Public Health updated the public on the specific local case and reminds everyone of the importance of vaccination to protect the community.

September 12th 2025

Merck reported the results for its phase 3 trial for its vaccine, Capvaxive, which was found to be noninferior to the pneumococcal 23-valent polysaccharide vaccine (PPSV23) for each of the 12 serotypes shared between the vaccines.

September 10th 2025

Corner Therapeutics says its "hyperactivator" adjuvant technology can offer protection against all virus strains.